EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation

He Zhang, Yang Bai, Jiatong Li, Ting Chen, Guanning Shang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von He Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Osteosarcoma, Ubiquitination, Forkhead Box Protein O1, F-Box Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence has demonstrated that F‐box protein 22 (FBXO22) participates in tumour development and progression in various types of human malignancies. However, the functions and detailed molecular mechanisms of FBXO22 in osteosarcoma tumorigenesis and progression remain elusive. In this study, we aimed to determine the effects of FBXO22 on the cell proliferation, migration and invasion of osteosarcoma cells using cell counting kit‐8 and Matrigel Transwell approaches. Moreover, we explored the molecular mechanisms by which FBXO22 mediated oncogenesis and progression in osteosarcoma via Western blotting, immunoprecipitation and ubiquitination. We found that FBXO22 depletion inhibited the proliferation, migration and invasion of osteosarcoma cells, whereas FBXO22 overexpression increased the proliferation and motility of osteosarcoma cells. Mechanistically, FBXO22 promoted the ubiquitination and degradation of FoxO1 in osteosarcoma cells. FBXO22 depletion reduced cell proliferation and motility via regulation of FoxO1. Taken together, our findings provide new insight into FBXO22‐induced osteosarcoma tumorigenesis. The inhibition of FBXO22 could be a promising strategy for the treatment of osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaUbiquitinationForkhead Box Protein O1F-Box ProteinsCell ProliferationCell MovementGene Expression Regulation, NeoplasticHumansCell Line, TumorProteolysisDisease ProgressionBone NeoplasmsNeoplasm InvasivenessCarcinogenesisReceptors, Cytoplasmic and Nuclear

Stichwörter der Autor:innen

FBXO22FoxO1degradationosteosarcomaubiquitination

Substanzen

Forkhead Box Protein O1F-Box ProteinsFOXO1 protein, humanFBXO22 protein, humanReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Nursing, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Guanning Shang

Zitieren

APA

Zhang, H., Bai, Y., Li, J., Chen, T., & Shang, G. (2024). FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70021

Vancouver

Zhang H, Bai Y, Li J, Chen T, Shang G. FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70021

BibTeX
@article{Zhang2024,
  author = {Zhang, He and Bai, Yang and Li, Jiatong and Chen, Ting and Shang, Guanning},
  title = {FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70021}
}
Kostenlos starten →